vs
Side-by-side financial comparison of Agilent Technologies (A) and Teradyne (TER). Click either name above to swap in a different company.
Agilent Technologies is the larger business by last-quarter revenue ($1.8B vs $1.3B, roughly 1.4× Teradyne). Teradyne runs the higher net margin — 31.1% vs 17.0%, a 14.1% gap on every dollar of revenue. On growth, Teradyne posted the faster year-over-year revenue change (87.0% vs 7.0%). Over the past eight quarters, Teradyne's revenue compounded faster (32.6% CAGR vs 6.9%).
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emissi...
Teradyne, Inc. is an American automatic test equipment (ATE) designer and manufacturer based in North Reading, Massachusetts. Its high-profile customers include Samsung, Qualcomm, Intel, Analog Devices, Texas Instruments and IBM.
A vs TER — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.8B | $1.3B |
| Net Profit | $305.0M | $398.9M |
| Gross Margin | 52.6% | 60.9% |
| Operating Margin | 19.6% | 36.9% |
| Net Margin | 17.0% | 31.1% |
| Revenue YoY | 7.0% | 87.0% |
| Net Profit YoY | -4.1% | — |
| EPS (diluted) | $1.07 | $2.53 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.8B | $1.3B | ||
| Q4 25 | $1.9B | $1.1B | ||
| Q3 25 | $1.7B | $769.2M | ||
| Q2 25 | $1.7B | $651.8M | ||
| Q1 25 | $1.7B | $685.7M | ||
| Q4 24 | $1.7B | $752.9M | ||
| Q3 24 | $1.6B | $737.3M | ||
| Q2 24 | $1.6B | $729.9M |
| Q1 26 | $305.0M | $398.9M | ||
| Q4 25 | $434.0M | $257.2M | ||
| Q3 25 | $336.0M | $119.6M | ||
| Q2 25 | $215.0M | $78.4M | ||
| Q1 25 | $318.0M | $98.9M | ||
| Q4 24 | $351.0M | $146.3M | ||
| Q3 24 | $282.0M | $145.6M | ||
| Q2 24 | $308.0M | $186.3M |
| Q1 26 | 52.6% | 60.9% | ||
| Q4 25 | 53.2% | 57.2% | ||
| Q3 25 | 51.1% | 58.4% | ||
| Q2 25 | 51.9% | 57.2% | ||
| Q1 25 | 53.5% | 60.6% | ||
| Q4 24 | 53.9% | 59.4% | ||
| Q3 24 | 54.2% | 59.2% | ||
| Q2 24 | 54.4% | 58.3% |
| Q1 26 | 19.6% | 36.9% | ||
| Q4 25 | 23.8% | 27.1% | ||
| Q3 25 | 20.7% | 18.9% | ||
| Q2 25 | 18.0% | 13.9% | ||
| Q1 25 | 22.4% | 17.6% | ||
| Q4 24 | 24.0% | 20.4% | ||
| Q3 24 | 21.1% | 20.6% | ||
| Q2 24 | 23.1% | 28.8% |
| Q1 26 | 17.0% | 31.1% | ||
| Q4 25 | 23.3% | 23.7% | ||
| Q3 25 | 19.3% | 15.5% | ||
| Q2 25 | 12.9% | 12.0% | ||
| Q1 25 | 18.9% | 14.4% | ||
| Q4 24 | 20.6% | 19.4% | ||
| Q3 24 | 17.9% | 19.8% | ||
| Q2 24 | 19.6% | 25.5% |
| Q1 26 | $1.07 | $2.53 | ||
| Q4 25 | $1.53 | $1.62 | ||
| Q3 25 | $1.18 | $0.75 | ||
| Q2 25 | $0.75 | $0.49 | ||
| Q1 25 | $1.11 | $0.61 | ||
| Q4 24 | $1.23 | $0.89 | ||
| Q3 24 | $0.97 | $0.89 | ||
| Q2 24 | $1.05 | $1.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.8B | $241.9M |
| Total DebtLower is stronger | $3.0B | $0 |
| Stockholders' EquityBook value | $6.9B | — |
| Total Assets | $12.8B | $4.4B |
| Debt / EquityLower = less leverage | 0.44× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $1.8B | $241.9M | ||
| Q4 25 | $1.8B | $293.8M | ||
| Q3 25 | $1.5B | $272.7M | ||
| Q2 25 | $1.5B | $339.3M | ||
| Q1 25 | $1.5B | $475.6M | ||
| Q4 24 | $1.3B | $553.4M | ||
| Q3 24 | $1.8B | $510.0M | ||
| Q2 24 | $1.7B | $421.9M |
| Q1 26 | $3.0B | $0 | ||
| Q4 25 | $3.0B | — | ||
| Q3 25 | $3.4B | — | ||
| Q2 25 | $3.3B | — | ||
| Q1 25 | $3.3B | — | ||
| Q4 24 | $3.3B | — | ||
| Q3 24 | $2.1B | — | ||
| Q2 24 | $2.1B | — |
| Q1 26 | $6.9B | — | ||
| Q4 25 | $6.7B | $2.8B | ||
| Q3 25 | $6.4B | $2.7B | ||
| Q2 25 | $6.1B | $2.8B | ||
| Q1 25 | $6.0B | $2.8B | ||
| Q4 24 | $5.9B | $2.8B | ||
| Q3 24 | $5.9B | $2.9B | ||
| Q2 24 | $6.2B | $2.7B |
| Q1 26 | $12.8B | $4.4B | ||
| Q4 25 | $12.7B | $4.2B | ||
| Q3 25 | $12.2B | $4.0B | ||
| Q2 25 | $12.2B | $3.8B | ||
| Q1 25 | $11.9B | $3.7B | ||
| Q4 24 | $11.8B | $3.7B | ||
| Q3 24 | $11.0B | $3.8B | ||
| Q2 24 | $10.9B | $3.6B |
| Q1 26 | 0.44× | — | ||
| Q4 25 | 0.45× | — | ||
| Q3 25 | 0.53× | — | ||
| Q2 25 | 0.55× | — | ||
| Q1 25 | 0.56× | — | ||
| Q4 24 | 0.57× | — | ||
| Q3 24 | 0.36× | — | ||
| Q2 24 | 0.34× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $268.0M | $265.1M |
| Free Cash FlowOCF − Capex | $175.0M | — |
| FCF MarginFCF / Revenue | 9.7% | — |
| Capex IntensityCapex / Revenue | 5.2% | — |
| Cash ConversionOCF / Net Profit | 0.88× | 0.66× |
| TTM Free Cash FlowTrailing 4 quarters | $993.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $268.0M | $265.1M | ||
| Q4 25 | $545.0M | $281.6M | ||
| Q3 25 | $362.0M | $49.0M | ||
| Q2 25 | $221.0M | $182.1M | ||
| Q1 25 | $431.0M | $161.6M | ||
| Q4 24 | $481.0M | $282.6M | ||
| Q3 24 | $452.0M | $166.3M | ||
| Q2 24 | $333.0M | $216.1M |
| Q1 26 | $175.0M | — | ||
| Q4 25 | $452.0M | $218.8M | ||
| Q3 25 | $259.0M | $2.4M | ||
| Q2 25 | $107.0M | $131.7M | ||
| Q1 25 | $334.0M | $97.6M | ||
| Q4 24 | $388.0M | $225.2M | ||
| Q3 24 | $360.0M | $114.4M | ||
| Q2 24 | $230.0M | $171.2M |
| Q1 26 | 9.7% | — | ||
| Q4 25 | 24.3% | 20.2% | ||
| Q3 25 | 14.9% | 0.3% | ||
| Q2 25 | 6.4% | 20.2% | ||
| Q1 25 | 19.9% | 14.2% | ||
| Q4 24 | 22.8% | 29.9% | ||
| Q3 24 | 22.8% | 15.5% | ||
| Q2 24 | 14.6% | 23.5% |
| Q1 26 | 5.2% | — | ||
| Q4 25 | 5.0% | 5.8% | ||
| Q3 25 | 5.9% | 6.1% | ||
| Q2 25 | 6.8% | 7.7% | ||
| Q1 25 | 5.8% | 9.3% | ||
| Q4 24 | 5.5% | 7.6% | ||
| Q3 24 | 5.8% | 7.0% | ||
| Q2 24 | 6.5% | 6.1% |
| Q1 26 | 0.88× | 0.66× | ||
| Q4 25 | 1.26× | 1.09× | ||
| Q3 25 | 1.08× | 0.41× | ||
| Q2 25 | 1.03× | 2.32× | ||
| Q1 25 | 1.36× | 1.63× | ||
| Q4 24 | 1.37× | 1.93× | ||
| Q3 24 | 1.60× | 1.14× | ||
| Q2 24 | 1.08× | 1.16× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
A
| Service Other | $525.0M | 29% |
| Chemicaland Energy Market | $422.0M | 23% |
| Agilent Cross Lab | $273.0M | 15% |
| Environmentaland Forensics Market | $177.0M | 10% |
| Food Market | $166.0M | 9% |
| Academiaand Government Market | $130.0M | 7% |
| Applied Markets | $98.0M | 5% |
TER
Segment breakdown not available.
